Promising drug by UAlberta researchers could save millions of lives.
Heart failure patients who are getting by on existing drug therapies can look forward to a far more effective medicine in the next five years or so, thanks to University of Alberta researchers.
Heart specialist Gavin Oudit and his research team discovered a molecule—angiotensin converting enzyme 2 (ACE2)—that works to restore balance to the pathways responsible for chronic and acute heart failure, including in patients with advanced heart failure who underwent heart transplants.
In conducting their research, Oudit and his team used genetic mapping technology to discover to an extent not seen before how the renin-angiotensin system (RAS)—which regulates the body’s sodium balance, fluid volume and blood pressure—is at play in both acute and chronic heart failure.
It led to the creation of recombinant human ACE2, a new drug that was manufactured by Apeiron Biologics in collaboration with Oudit. It was bought by GlaxoSmithKline, which recently successfully completed phase II clinical trials that tested for the safety and efficacy of the drug on hundreds of patients. The new drug is expected to be on the market in the next three to five years.
Oudit added that using mapping technology has also made it possible to individualize the dose a patient needs, allowing for a truly personalized treatment plan for heart failure patients in the future. The study also broke ground by showing how ACE2 can be used in heart transplant patients with heart failure.
About six million Canadians will develop heart failure, a common condition that most often happens after the heart has been damaged or weakened by heart attack or stroke. According to the Canadian Heart and Stroke Foundation, the two most common causes of heart failure are heart attacks and high blood pressure. When someone has heart failure, the heart either can’t accept the inflow of blood or pump it out, or both.
“This research is a terrific example of how the university works together synergistically to develop world-class research and translate that into medicines that impact patient outcomes,” added Oudit.
Learn more: New hope for treating heart failure
Receive an email update when we add a new ARTIFICIAL SYNAPSES article.
The Latest on: Heart failure
via Google News
The Latest on: Heart failure
- Heart disease risk grows as women move through menopauseon February 3, 2020 at 12:01 am
A marker for heart disease risk considerably worsens as women transition through menopause, according to a new analysis from the largest and longest running study of women's health in midlife ...
- February focus: Five unbeatable steps to better heart healthon February 2, 2020 at 9:01 pm
Take a cue from Cupid during February and set your sights on the heart – pint-sized bow and arrow not required. Instead, show your four chambers some love with a five-pronged approach to better heart ...
- Rheumatic Heart Disease Market to Grow at a Moderate Pace Through 2026on February 2, 2020 at 5:49 pm
Ameco Research, Latest Research Report on titled "Global Rheumatic Heart Disease Market – Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027". In the coming years, the ...
- Lanka Hospitals partners with Rotary to provide treatment to children with congenital heart diseaseon February 2, 2020 at 4:00 pm
Lanka Hospitals has partnered with the Rotary Club of Colombo Metropolitan, the Rotary Club of Newton, New Jersey USA and Gift of Life International.The objective of the partnership is to support the ...
- A President’s Gift to Heart Disease Awarenesson February 2, 2020 at 2:24 pm
In February 1964, President Lyndon B. Johnson designated the first American Heart Month. Fifty-six years later, we continue to raise awareness about heart disease every February. Like millions of ...
- People Urged To ‘Go Red For Women’ On Feb. 7 To Raise Awareness Of Heart Disease In Womenon February 2, 2020 at 6:24 am
NEW YORK (CBSNewYork) — February is American Heart Month. According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death for women in the United States. But ...
- Innovations in high-risk heart failure treatments: transplants and technologyon January 31, 2020 at 9:04 pm
Leading medical centers, including Temple University Hospital, are finding new ways to approve more people for heart transplants, including those with coexisting health conditions. An estimated 6 ...
- Congenital heart disease more deadly in low-income countrieson January 31, 2020 at 9:09 am
Even though mortality from congenital heart disease (CHD) has declined over the last three decades as diagnosis and treatments have advanced, the chances for a child to survive a CHD diagnosis ...
- Two sisters, one near-death experience, and a warning to others about heart diseaseon January 31, 2020 at 2:08 am
“We don't look like the average people you might expect to have heart disease,” Marino said. The two sisters have become leading advocates for the Buffalo Niagara affiliate of the American Heart ...
via Bing News